Analysis of Virus Filtration market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
In 2022, worldwide virus filtration system sales have reached US$ 4 billion. The global virus filtration market is anticipated to surge ahead at a CAGR of 13% to reach US$ 6.5 billion by 2026.
Demand for kits & reagents is expected to increase at an impressive CAGR of 15% and reach a market valuation of US$ 5 billion by the end of 2026.
Virus Filtration Market Size (2022E)
US$ 4 Billion
Forecasted Market Value (2026F)
US$ 6.5 Billion
Global Market Growth Rate (2022-2026)
U.S. Market Value (2022)
US$ 1 Billion
China Market Value (2026)
US$ 900 Million
Key Companies Profiled
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
The process of virus filtration keeps the environment clean from bacteria, germs, and other diseases. This is because their existence in laboratories taints the samples, air, and water. As a result, virus filtration is required. Many end user verticals employ virus filtration, a powerful, dependable virus filtration technology. The cleanliness of the lab is effectively maintained by virus filtration technology.
By filtering buffer solutions and media, virus filters serve as a protective medium or barrier for bioreactors. The expansion of the pharmaceutical and biotechnology industries, as well as government support for these sectors, are key factors driving the viral filtration industry.
Based on application, the virus filtration market is segmented into biological, medical devices, water purifications, air purifications, and others. Hotels and restaurants utilize air purification systems with activated carbon and HEPA to remove smoke, odour, and airborne particles from the air, enhancing the quality of the air in the spaces.
To maintain indoor air quality for both patients and staff working in these facilities, allergens, airborne pathogens, and odours are removed from the air using air purifiers in dentistry and medical laboratories, veterinary hospitals, animal kennels, boarding kennels, clinics, and hospitals. Thus, the demand for virus filtration systems for air purification is gaining traction.
One of the primary factors favourably affecting the market is the growing global elderly population, which is also accompanied by an increase in the prevalence of chronic health diseases.
Furthermore, the growing need for vaccines and possible medicines to treat patients in life-threatening situations is encouraging the use of viral filtration in convalescent plasma to reduce inflammatory mediators. A good market outlook is also being formed by the growing worries about the emergence of various virus varieties in the environment.
According to Fact.MR, a market research and competitive intelligence provider, expanding at a CAGR of 13%, the global virus filtration market is projected to reach US$ 6.5 billion by 2026.
“Technological Developments in Monoclonal Antibodies (MAbs) Production for Virus Elimination Driving Market Share of Virus Filtration Systems”
The prospects in the viral filtration market have been boosted by the demand for virus elimination during monoclonal antibodies (MAbs) production procedures. In the last few years, there have been notable technological advancements in MAb downstream procedures, and new MAb platforms now have promising futures.
Manufacturers of viral filtration solutions have been forced to concentrate on a variety of performance factors due to the life sciences industries' increased need for high-concentration monoclonal antibody solutions.
For example, important factors are related to strong flow, rapid clearing, and large capacity. There are new ways to set up viral filters for screening. Most significantly, end users in the life sciences sector are looking to embrace virus filtration technologies that enable them to filter viruses affordably.
Due to the increased need for MAb production techniques, the trend has gained momentum recently.
Demand for ongoing technical advancements in the virus filtration market has been pushed by the rising number of plasma processors in clinical research.
Growing number of submissions for experimental novel drugs is also supporting revenue expansion. The market is also being boosted by the expanding usage of mammalian cell lines in MAb manufacturing.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
“Rise in Protein Structure Research Activities Aiding Development of Virus Filtration Products”
Device manufacturers are eager to provide GMP-compliant products. To satisfy the demands of particular MAb projects, size exclusion chromatography has undergone advancements.
Total purification costs are a significant factor in determining the demand for different devices in such programmes. The market for virus filtration solutions has benefited significantly from the development of further MAbs.
Such research and development projects have gained momentum due to tools for removing viruses during the still-emerging COVID-19 pandemic. Finding solutions for infection prevention, particularly to stop community transmission, is the focus of numerous clinical trials.
This has also sparked MAb production research, significantly impacting the dynamics of market growth for viral filtration systems. An increase in protein structure research also encourages the development of new products in the market.
“North America Handsomely Leads Virus Filtration Market Due to Support for Product Development from Pharmaceutical, Biotechnology, & CROs”
The market for virus filtration solutions in North America is expected to have a positive outlook between 2022 and 2026. It is anticipated that pharmaceutical, biotechnology, and contract research organisations (CROs) will invest in virus filtration solutions across North America. Respective governments in the region are anticipated to increase their spending and improve the healthcare system, which will foster regional development.
Due to the significant demand for novel virus filtration products for research and the development and manufacturing of biologics, Europe is the second-largest market for virus filtration systems.
The region's market is also anticipated to be driven by highly developed healthcare infrastructure and significant investments in technology transfer, particularly in Germany, the United Kingdom, and France.
During the forecast period, Asia Pacific market is anticipated to have the highest CAGR due to an increase in the number of trauma cases. According to estimates, the regional market's growth will be fueled by the existence of untapped growth prospects in the quickly expanding Asian economies such as China, India, and Indonesia.
Manufacturers of biologics and medical devices are drawn to these locations for market development because of the expanding government support for manufacturing, the existence of CROs, the affordability of labour, and the relative leniency of the regulatory environment.
“Increased Investments in R&D of Virus Filtration Technology by Biopharmaceutical Companies”
The United States market is valued at US$ 1 billion, in 2022. The United States holds the highest market share in the North America virus filtration market.
Furthermore, regulatory oversight of occurrences involving viral infections in manufacturing processes has expanded recently. The need for biologics is anticipated to boost the viral filtration market over the forecast period due to increased investments in research and development by biopharmaceutical companies.
“Government Support & Their Favourable Policies Boosts Sales of Virus Filtration Systems”
Robust economic growth in china is supporting biotechnology and pharmaceutical companies to increase their revenue share. The use of filtration solutions such as chromatographic reagents and kits is required to prevent the denaturation of proteins or the variations in protein structure, which may negatively impact the demand for these products.
Biological development, such as the creation of biopharmaceutical drugs, necessitates characteristic features, and even a slight difference in the protein structure could change the efficiency, quality, and safeness of medicine.
Thus, government support and favourable policies support the sales of virus filtration systems. The china virus filtration market is expected to reach a valuation of US$ 900 million in the year 2026.
“Kits & Reagents Driving Virus Filtration Market Growth Due to Improved Virus Detection Aspect”
The kits & reagents segment is expected to expand at an impressive CAGR of 15% from 2022-2026. In the viral filtration industry, kits & reagents are a very significant segment.
The reagents aid in lowering the chance of iatrogenic viral transmission. The reagents aid in determining the virus that is most likely to infect the cell substrate or any other reagents or components employed in the procedure when evaluating the process.
Two of the well-known manufacturers of reagents and kits for virus filtration are Qiagen and Merck Millipore. Blood, plasma, serum, bodily fluids, any monoclonal antibody, and recombinant proteins are examples of samples utilized in the manufacturing of biopharmaceuticals.
Even some pharmaceutical and biologic-based businesses have chosen to increase their development costs for vaccines, protein treatments, blood products, cellular therapy, gene therapy, tissue goods, and stem cell products. The market under study is being driven by the demand for these kits and reagents.
Don't Need a Global Report?
Save 40% on Country & Region specific reports
Top companies in virus filtration offer cutting-edge items through reliable distribution networks all across the world.
To increase their revenue share in the market, top manufacturers engage in acquisitions and mergers strategic alliances, and the creation of new products. Companies can broaden their established businesses and geographic reach through mergers and acquisitions.
Another important tactic adopted by businesses to improve their market position is the launch of innovative products.
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunitiesBuy Now
Get A Special pricing for start-ups and universitiesEnquiry Before Buying
- Humble, Yet Honored -
- Related Reports -
The global virus filtration market currently accounts for a valuation of US$ 4 billion.
Worldwide sales of virus filtration solutions are expected to reach US$ 6.5 billion in 2026.
Abbott Laboratories, Asahi Kasei Medical Co., Ltd., BioMérieux SA, Bio-Rad Laboratories, Inc., and F. Hoffmann-La Roche AG are key manufacturers of virus filtration systems.
Demand for kits and reagents is expected to surge at 15% CAGR through 2026.
From 2022 to 2026, the global virus filtration market is projected to expand at 13% CAGR.
Need An Exclusive Report For Your Unique Requirement?